# Arbutus Biopharma Corp: Form 8-K, filed Jul 18, 2019

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2019-07-18
- Accepted by EDGAR: Jul 18, 2019, 16:05 ET
- Period: 2019-07-15
- Accession: 0001104659-19-040934
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000110465919040934/a19-12981_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000110465919040934/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000110465919040934/a19-12981_18k.htm

Filed Jul 18, 2019.
Source: SEC EDGAR, the filing index for accession 0001104659-19-040934. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.